Clinical Trial 44755

Imperial, CA 92251


Summary:

Study 44755 Flyer
Click image to enlarge

A Phase 4, Multicenter, 2-part Study Composed of a 1-Year Randomized, Double-blind, Parallel-group, Placebo-controlled, Active-comparator, Dose-optimization Evaluation followed by a 1-Year Open-label Evaluation to Assess the Safety and Efficacy of Guanfacine Hydrochloride Prolonged-release (SPD503) in Children and Adolescents aged 6 to 17 Years with Attention-deficit/Hyperactivity Disorder


Criteria:

-Be between the ages of 6-17 years old

-Be sufferring from ADHD or already be diagnosed by a doctor

-Prior stimulant therapy did not work or was not suitable for your child or tolearted

-A parent or legal guardian who will bring the child or adolescent in for each visit and oversee their participation in the study and ensure they follow all the study procedures

-Child or adolescent should not have any issues swallowing tablets or capsules

-Child or adolescent should not have any issues with blood draws, we will need to collect a few blood samples occassionaly throughout the study.


Qualified Participants May Receive:

-Free study related medication

-Free study related medical care

-Compensation for their time and travel

-Opportunity to qualify for the open label extension portion of the study


Available At:

Sun Valley Research Center, Inc.
2417 Marshall Avenue, Suite 1
Imperial, CA 92251
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 250 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.